Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer

BACKGROUND: Our previous study reported the favorable efficacy and good tolerance associated with a modified XELOX adjuvant chemotherapy with eight cycles of capecitabine and six cycles of oxaliplatin for operated stage III colon cancer. The current study aimed to confirm the feasibility of modified...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Pharmacol
Main Authors: Peng, Jianhong, Li, Weihao, Fan, Wenhua, Zhou, Wenhao, Zhu, Ying, Li, Xueying, Pan, Zhizhong, Lin, Xiaoping, Lin, Junzhong
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543913/
https://ncbi.nlm.nih.gov/pubmed/33071795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.583091
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares